Loading...
Nivolumab in the treatment of metastatic squamous non-small cell lung cancer: a review of the evidence
Progress in the treatment of patients with advanced stage squamous cell non-small cell lung cancer (NSCLC) has been limited. An improvement in the understanding of tumor immunosurveillance has resulted in the development of the immune checkpoint inhibitors such as nivolumab. Nivolumab (Opdivo(®)), a...
Saved in:
| Published in: | Ther Adv Respir Dis |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
SAGE Publications
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933620/ https://ncbi.nlm.nih.gov/pubmed/27480166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465816661091 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|